Identification of specific differentially expressed antigens
CA 2361246 C · Owner: Kaufmann, Stefan H. E. · Inventors: Raupach, Barbel; Zimny-Arndt, Ursula; Mattow, Jens
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to compositions useful in immunization against pathogenic organisms of the genus Mycobacterium and for diagnostic purposes. In particular, the present invention relates to a composition comprising at least one protein which is differentially expressed in a virulent strain as compared to an avirulent strain of Mycobacteria. Furthermore the invention , relates to compositions comprising fusion proteins antigenic fragments, nucleic acid molecules encoding the aforementioned proteinaceous compounds and/or antibodies thereto. Additionally the invention relates to , pharmaceutical and diagnostic compositions comprising or employing compounds of the invention. …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 28, 2000 and granted April 16, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 28, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 28, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.